antibody
Harbour BioMed’s AI-Enabled Obesity Antibody LET003 Has IND Accepted
Harbour BioMed announced on November 18, 2026 that China’s National Medical Products Administration had accepted the investigational new drug (IND) application …
Advancing AI for biology: Teaching models to design and characterize antibodies
Three new papers from Amazon Bio Discovery address bottlenecks in AI-driven antibody engineering, from benchmarking binding predictors to experimentally validat…





